{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:56:53Z","timestamp":1790420213080,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s12026-020-09152-6","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T09:04:34Z","timestamp":1600419874000},"page":"310-313","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":234,"title":["Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2111-4608","authenticated-orcid":false,"given":"Darja","family":"Kanduc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,18]]},"reference":[{"key":"9152_CR1","doi-asserted-by":"publisher","unstructured":"Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical features of 69 cases with Coronavirus Disease 2019 in Wuhan, China. Clin Infect Dis. 2020:ciaa272. https:\/\/doi.org\/10.1093\/cid\/ciaa272.","DOI":"10.1093\/cid\/ciaa272"},{"key":"9152_CR2","doi-asserted-by":"publisher","first-page":"108426","DOI":"10.1016\/j.clim.2020.108426","volume":"215","author":"D Kanduc","year":"2020","unstructured":"Kanduc D, Shoenfeld Y. On the molecular determinants of the SARS-CoV-2 attack. Clin Immunol. 2020;215:108426. https:\/\/doi.org\/10.1016\/j.clim.2020.108426.","journal-title":"Clin Immunol"},{"key":"9152_CR3","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1089\/mab.2013.0090","volume":"33","author":"MB Oldstone","year":"2014","unstructured":"Oldstone MB. Molecular mimicry: its evolution from concept to mechanism as a cause of autoimmune diseases. Monoclon Antib Immunodiagn Immunother. 2014;33:158\u201365. https:\/\/doi.org\/10.1089\/mab.2013.0090.","journal-title":"Monoclon Antib Immunodiagn Immunother"},{"key":"9152_CR4","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.2741\/s341","volume":"4","author":"D Kanduc","year":"2012","unstructured":"Kanduc D. Peptide cross-reactivity: the original sin of vaccines. Front Biosci. 2012;4:1393\u2013401. https:\/\/doi.org\/10.2741\/s341.","journal-title":"Front Biosci"},{"key":"9152_CR5","doi-asserted-by":"publisher","first-page":"13365","DOI":"10.1128\/JVI.01169-07","volume":"81","author":"AN Vlasova","year":"2007","unstructured":"Vlasova AN, Zhang X, Hasoksuz M, Nagesha HS, Haynes LM, Fang Y, et al. Two-way antigenic cross-reactivity between Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and group 1 animal CoVs is mediated through an antigenic site in the N-terminal region of the SARS-CoV nucleoprotein. J Virol. 2007;81:13365\u201377. https:\/\/doi.org\/10.1128\/JVI.01169-07.","journal-title":"J Virol"},{"key":"9152_CR6","doi-asserted-by":"publisher","unstructured":"Cappello F. COVID-19 and molecular mimicry: the Columbus\u2019 egg? J Clin Neurosci. https:\/\/doi.org\/10.1016\/j.jocn.2020.05.015.","DOI":"10.1016\/j.jocn.2020.05.015"},{"key":"9152_CR7","doi-asserted-by":"publisher","first-page":"108480","DOI":"10.1016\/j.clim.2020.108480","volume":"217","author":"A Vojdani","year":"2020","unstructured":"Vojdani A, Kharrazianb D. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin Immunol. 2020;217:108480. https:\/\/doi.org\/10.1016\/j.clim.2020.108480.","journal-title":"Clin Immunol"},{"issue":"3","key":"9152_CR8","doi-asserted-by":"publisher","first-page":"E33","DOI":"10.3390\/antib9030033","volume":"9","author":"D Kanduc","year":"2020","unstructured":"Kanduc D. From anti-SARS-CoV-2 immune responses to COVID-19 via molecular mimicry. Antibodies (Basel). 2020;9(3):E33. https:\/\/doi.org\/10.3390\/antib9030033.","journal-title":"Antibodies (Basel)"},{"key":"9152_CR9","doi-asserted-by":"publisher","unstructured":"Grifoni A, Weiskopf D, Ramirez SI, Mateus J, Dan JM, Rydyznski C, et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell. 2020. https:\/\/doi.org\/10.1016\/j.cell.2020.05.015.","DOI":"10.1016\/j.cell.2020.05.015"},{"key":"9152_CR10","doi-asserted-by":"publisher","first-page":"100090","DOI":"10.1016\/j.fsir.2020.100090","volume":"2","author":"NMA Parry","year":"2020","unstructured":"Parry NMA. COVID-19 and pets: when pandemic meets panic. Forensic Sci Int. 2020;2:100090. https:\/\/doi.org\/10.1016\/j.fsir.2020.100090.","journal-title":"Forensic Sci Int"},{"key":"9152_CR11","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1136\/vr.m1194","volume":"186","author":"A Almendros","year":"2020","unstructured":"Almendros A. Can companion animals become infected with Covid-19? Vet Rec. 2020;186:388\u20139. https:\/\/doi.org\/10.1136\/vr.m1194.","journal-title":"Vet Rec"},{"key":"9152_CR12","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1136\/vr.m1455","volume":"186","author":"X Li","year":"2020","unstructured":"Li X. Can cats become infected with Covid-19? Vet Rec. 2020;186:457\u20138. https:\/\/doi.org\/10.1136\/vr.m1455.","journal-title":"Vet Rec"},{"key":"9152_CR13","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/s1472-6483(10)61702-6","volume":"6","author":"G Pieczenik","year":"2003","unstructured":"Pieczenik G. Are the universes of antibodies and antigens symmetrical? Reprod BioMed Online. 2003;6:154\u20136. https:\/\/doi.org\/10.1016\/s1472-6483(10)61702-6.","journal-title":"Reprod BioMed Online"},{"key":"9152_CR14","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/psc.2419","volume":"18","author":"D Kanduc","year":"2012","unstructured":"Kanduc D. Homology, similarity, and identity in peptide epitope immunodefinition. J Pept Sci. 2012;18:487\u201394. https:\/\/doi.org\/10.1002\/psc.2419.","journal-title":"J Pept Sci"},{"key":"9152_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2174\/1389203711314020003","volume":"14","author":"D Kanduc","year":"2013","unstructured":"Kanduc D. Pentapeptides as minimal functional units in cell biology and immunology. Curr Protein Pept Sci. 2013;14:111\u201320. https:\/\/doi.org\/10.2174\/1389203711314020003.","journal-title":"Curr Protein Pept Sci"},{"key":"9152_CR16","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.2174\/1871520615666150716105543","volume":"15","author":"D Kanduc","year":"2015","unstructured":"Kanduc D. Immunogenicity, immunopathogenicity, and immunotolerance in one graph. Anti Cancer Agents Med Chem. 2015;15:1264\u20138. https:\/\/doi.org\/10.2174\/1871520615666150716105543.","journal-title":"Anti Cancer Agents Med Chem"},{"key":"9152_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2174\/1874226201808010016","volume":"8","author":"D Kanduc","year":"2018","unstructured":"Kanduc D, Shoenfeld Y. Inter-pathogen peptide sharing and the original antigenic sin: solving a paradox. Open Immunol J. 2018;8:16\u201327. https:\/\/doi.org\/10.2174\/1874226201808010016.","journal-title":"Open Immunol J"},{"key":"9152_CR18","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1093\/bioinformatics\/btt484","volume":"29","author":"C Chen","year":"2013","unstructured":"Chen C, Li Z, Huang H, Suzek BE, Wu CH, UniProt Consortium. A fast peptide match service for UniProt knowledgebase. Bioinformatics. 2013;29:2808\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btt484.","journal-title":"Bioinformatics"},{"key":"9152_CR19","doi-asserted-by":"publisher","unstructured":"Yu J, Tostanoski LH, Peter L, Mercado NB, McMahan K, Mahrokhian SH, et al. DNA vaccine protection against SARS-CoV-2 in rhesus macaque. Science. 2020:eabc6284. https:\/\/doi.org\/10.1126\/science.abc6284.","DOI":"10.1126\/science.abc6284"},{"key":"9152_CR20","doi-asserted-by":"publisher","first-page":"e411","DOI":"10.1371\/journal.pmed.0030411","volume":"3","author":"RJ Hogan","year":"2006","unstructured":"Hogan RJ. Are nonhuman primates good models for SARS? PLoS Med. 2006;3:e411. https:\/\/doi.org\/10.1371\/journal.pmed.0030411.","journal-title":"PLoS Med"},{"key":"9152_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030149","volume":"3","author":"JV Lawler","year":"2006","unstructured":"Lawler JV, Endy TP, Hensley LE, Garrison A, Fritz EA, Lesar M, et al. Cynomolgus macaque as an animal model for severe acute respiratory syndrome. PLoS Med. 2006;3:e149. https:\/\/doi.org\/10.1371\/journal.pmed.0030149.","journal-title":"PLoS Med"},{"key":"9152_CR22","doi-asserted-by":"publisher","first-page":"11401","DOI":"10.1128\/JVI.78.20.11401-11404.2004","volume":"78","author":"T Rowe","year":"2004","unstructured":"Rowe T, Gao G, Hogan RJ, Crystal RG, Voss TG, Grant RL, et al. Macaque model for severe acute respiratory syndrome. J Virol. 2004;78:11401\u20134. https:\/\/doi.org\/10.1128\/JVI.78.20.11401-11404.2004.","journal-title":"J Virol"},{"key":"9152_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.virol.2004.09.030","volume":"330","author":"J McAuliffe","year":"2004","unstructured":"McAuliffe J, Vogel L, Roberts A, Fahle G, Fischer S, Shieh WJ, et al. Replication of SARS coronavirus administered into the respiratory tract of African green, rhesus and cynomolgus monkeys. Virology. 2004;330:8\u201315. https:\/\/doi.org\/10.1016\/j.virol.2004.09.030.","journal-title":"Virology"},{"key":"9152_CR24","volume-title":"\u201cNonhuman Primates in Biomedical Research\u201d, Vol. 2: Diseases","author":"LJ Lowenstine","year":"2012","unstructured":"Lowenstine LJ, Osborn KG. Respiratory system diseases of nonhuman primates. In: Abee CR, Keeling ME, Mansfield K, Tardif S, Morris T, editors. \u201cNonhuman Primates in Biomedical Research\u201d, Vol. 2: Diseases. Oxford: Academic Press, Elsevier; 2012. ISBN: 978-0-12-381366-4."},{"key":"9152_CR25","doi-asserted-by":"publisher","unstructured":"Roberts A, Paddock C, Vogel L, Butler E, Zaki S, Subbarao K. Aged BALB\/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans. J Virol. 2005;79:5833\u20138. https:\/\/doi.org\/10.1128\/JVI.79.9.5833-5838.2005.","DOI":"10.1128\/JVI.79.9.5833-5838.2005"},{"key":"9152_CR26","doi-asserted-by":"publisher","unstructured":"Nagata N, Iwata-Yoshikawa N, Taguchi F. Studies of severe acute respiratory syndrome coronavirus pathology in human cases and animal models. Vet Pathol. 2010;47(5):881\u201392. https:\/\/doi.org\/10.1177\/0300985810378760.","DOI":"10.1177\/0300985810378760"},{"key":"9152_CR27","doi-asserted-by":"publisher","unstructured":"Kanduc D. Epitopic peptides with low similarity to the host proteome: towards biological therapies without side effects. Expert Opin Biol Ther. 2009;9:45\u201353. https:\/\/doi.org\/10.1517\/14712590802614041.","DOI":"10.1517\/14712590802614041"},{"key":"9152_CR28","doi-asserted-by":"publisher","unstructured":"Kanduc D. \u201cSelf-nonself\u201d peptides in the design of vaccines. Curr Pharm Des. 2009;15:3283\u20139. https:\/\/doi.org\/10.2174\/138161209789105135.","DOI":"10.2174\/138161209789105135"},{"key":"9152_CR29","doi-asserted-by":"publisher","unstructured":"Kanduc D, Shoenfeld Y. From HBV to HPV: designing vaccines for extensive and intensive vaccination campaigns worldwide. Autoimmun Rev. 2016;15:1054\u201361. https:\/\/doi.org\/10.1016\/j.autrev.2016.07.030.","DOI":"10.1016\/j.autrev.2016.07.030"},{"key":"9152_CR30","doi-asserted-by":"publisher","unstructured":"Kanduc D. Hydrophobicity and the physico-chemical basis of immunotolerance. Pathobiology. 2020:1\u20139. https:\/\/doi.org\/10.1159\/000508903.","DOI":"10.1159\/000508903"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-020-09152-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-020-09152-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-020-09152-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T23:50:19Z","timestamp":1631922619000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-020-09152-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,18]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["9152"],"URL":"https:\/\/doi.org\/10.1007\/s12026-020-09152-6","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,18]]},"assertion":[{"value":"28 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"DK declares no conflicts. YS appears as a medical consultant in vaccine compensation court, USA.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}